Wang Chien-Chih, Hu Tsung-Ming, Chen Chien-Lung, Hong Chung-Chih, Chang Yu-Hui, Kao Chung-Lan
Department of Physical Medicine and Rehabilitation, Taipei Veterans General Hospital Yuli Branch, Hualien 981002, Taiwan.
Department of Physical Medicine and Rehabilitation, School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Pharmaceuticals (Basel). 2023 Aug 21;16(8):1186. doi: 10.3390/ph16081186.
We investigated whether hyaluronic acid (HA) injections can ameliorate ultrasound-detected synovitis in knee osteoarthritis (OA). We recruited 103 patients with symptomatic knee OA and ultrasound-detected synovitis and performed two ultrasound-guided fluid drainage procedures, followed by the administration of a low-molecular-weight HA injection (2.5 mL) in the subpatellar bursa, at a 2-week interval. Knee ultrasound imaging evaluations were performed before injection (baseline) and at 1 and 6 months after the second injection and included the measurements of synovial vascularity by using color Doppler ultrasound, synovial fluid depth over the suprapatellar bursa (SF), and synovial hypertrophy (SH). Initial clinical assessments included a visual analog scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). VAS scores decreased significantly at both 1-month and 6-month evaluations ( < 0.001). WOMAC scores also significantly decreased at 1 month ( < 0.001), but not at 6 months ( = 0.23). The ultrasound parameters did not significantly change, except color Doppler grading, which tended to decrease at the 6-month evaluation ( = 0.059). Our findings revealed that two ultrasound-guided HA injections following fluid drainage improved pain and knee function but did not considerably influence imaging-detected synovitis in patients with knee OA.
我们研究了透明质酸(HA)注射是否能改善超声检测到的膝关节骨关节炎(OA)滑膜炎。我们招募了103例有症状的膝关节OA且经超声检测有滑膜炎的患者,进行了两次超声引导下的积液引流操作,随后在髌下囊注射低分子量HA(2.5 mL),间隔2周。在注射前(基线)以及第二次注射后1个月和6个月进行膝关节超声成像评估,包括使用彩色多普勒超声测量滑膜血管、髌上囊上方的滑液深度(SF)和滑膜肥厚(SH)。初始临床评估包括视觉模拟评分(VAS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)。在1个月和6个月评估时VAS评分均显著降低(<0.001)。WOMAC评分在1个月时也显著降低(<0.001),但在6个月时未降低(=0.23)。除彩色多普勒分级在6个月评估时趋于降低(=0.059)外,超声参数无显著变化。我们的研究结果表明,积液引流后两次超声引导下的HA注射改善了疼痛和膝关节功能,但对膝关节OA患者成像检测到的滑膜炎影响不大。